GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we approach high blood sugar. These new drugs work by mimicking the body’s inherent GLP-1 hormone , https://bacteriastaticwater988027.techionblog.com/profile